Canada’s manufacturing capacity ‘factor’ in how much it pays for vaccines, says Anand

AstraZeneca has been rolling out its doses to countries at a price lower than some of its counterparts, but some fear contract details that allow it to declare the pandemic over this summer could lead to a hike in prices.

Procurement Minister Anita Anand, pictured in December 2020 with Prime Minister Justin Trudeau in her tracks, says Ottawa engaged in ‘aggressive’ negotiations with pharmaceutical companies about vaccine procurement beginning last August. A September note from a PMO worker suggests the feds paid more than $8 per dose for an AstraZeneca vaccine at the time.The Hill Times photograph by Sam Garcia

News

BY PALAK MANGAT

April 23, 2021

Canada’s limited domestic manufacturing capacity for vaccines was a “factor” in Ottawa paying more than what other countries have for AstraZeneca doses, Procurement Minister Anita Anand acknowledged Friday. Speaking to rep...

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.

Already a Subscriber?

Get Today’s Headlines Newsletter

Your quick scan of the news you need each weekday to be the smartest person in the room.

By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy